VKTX Viking Therapeutics Inc
24,452
$67.52
$0.515
(0.77%)
| Watchers | 24,452 |
| 52-Wk Low | $8.28 |
| 52-Wk High | $99.41 |
| Market Cap | $7.39B |
| Volume | 2.4M |
| 52-Wk High | $99.41 |
| 52-Wk Low | $8.28 |
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth TodayBenzinga • 5 days ago
read more...
Share to Feed
Viking Therapeutics (NASDAQ: VKTX), a clinical-stage company focused on developing novel therapeutics for metabolic and endocrine disorders, has been in the news, owing to updates from its obesity...
How Viking Therapeutics Stock Could 30x...
Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments...
read more...
Is Viking Therapeutics Incredibly Undervalued...
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024 Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024 PR Newswire SAN...